Hai-Qiang Mai Selected Research

Induction Chemotherapy

1/2022	Construction and validation of a biochemical signature to predict the prognosis and the benefit of induction chemotherapy in patients with nasopharyngeal carcinoma.
1/2022	Management of first-line palliative chemotherapy for post-treatment metastasis after gemcitabine plus cisplatin induction chemotherapy: Gemcitabine plus cisplatin and non-gemcitabine plus cisplatin chemotherapy.
1/2022	Development and validation of a transcriptomics-based gene signature to predict distant metastasis and guide induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
1/2022	Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial.
12/2021	Percent change in apparent diffusion coefficient and plasma EBV DNA after induction chemotherapy identifies distinct prognostic response phenotypes in advanced nasopharyngeal carcinoma.
10/2021	Management of suboptimal response to induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Re-induction therapy or direct to Radiotherapy?
12/2020	Identifying optimal candidates for induction chemotherapy among stage II-IVa nasopharyngeal carcinoma based on pretreatment Epstein-Barr virus DNA and nodal maximal standard uptake values of [18 F]-fluorodeoxyglucose positron emission tomography.
2/2020	Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein-Barr virus DNA level.
1/2020	Induction chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in the treatment of different risk locoregionally advanced nasopharyngeal carcinoma.
1/2020	Stratification of Candidates for Induction Chemotherapy in Stage III-IV Nasopharyngeal Carcinoma: A Large Cohort Study Based on a Comprehensive Prognostic Model.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hai-Qiang Mai Research Topics

Disease

165	Nasopharyngeal Carcinoma 11/2022 - 02/2002
52	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2005
47	Neoplasms (Cancer) 05/2022 - 04/2004
4	Carcinoma (Carcinomatosis) 01/2022 - 06/2015
4	Necrosis 11/2019 - 10/2013
3	Xerostomia 01/2020 - 05/2005
2	Carcinogenesis 01/2022 - 11/2015
2	Disease Progression 12/2021 - 11/2015
2	Anemia 10/2021 - 01/2015
2	Thrombocytopenia (Thrombopenia) 10/2021 - 01/2018
2	Body Weight (Weight, Body) 09/2021 - 11/2019
2	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2021 - 01/2021
2	Bites and Stings (Sting) 07/2020 - 11/2019
2	Mucositis 01/2020 - 08/2017
2	Hypoxia (Hypoxemia) 01/2020 - 04/2006
2	Stomatitis 10/2019 - 09/2013
2	Pain (Aches) 10/2019 - 10/2019
2	Neutropenia 12/2018 - 09/2013
2	Osteoradionecrosis 01/2017 - 09/2006
2	Nasopharyngitis 12/2015 - 12/2004
2	Lymphatic Metastasis 10/2015 - 10/2006
1	Fatty Liver 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Squamous Cell Carcinoma of Head and Neck 05/2021
1	Hypothyroidism 01/2021
1	Pathologic Constriction (Stenosis) 01/2021
1	Trismus (Lockjaw) 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Hearing Loss (Hearing Impairment) 01/2020
1	Dermatitis 01/2020
1	Circulating Neoplastic Cells 11/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 10/2019

Drug/Important Bio-Agent (IBA)

38	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 04/2013
21	Cisplatin (Platino)FDA LinkGeneric 10/2022 - 02/2005
9	Proteins (Proteins, Gene)FDA Link 11/2019 - 10/2006
7	Biological ProductsIBA 01/2022 - 11/2011
7	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2015
5	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 04/2004
5	Indicators and Reagents (Reagents)IBA 01/2017 - 06/2011
4	3-nitrophenyl 3-piperidinecarboxylate (MNPC)IBA 11/2022 - 01/2016
4	Capecitabine (Xeloda)FDA Link 01/2022 - 04/2004
4	Hemoglobins (Hemoglobin)IBA 09/2021 - 06/2005
4	Endothelin A ReceptorIBA 08/2013 - 05/2005
3	Gemcitabine FDA Link 01/2022 - 01/2020
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 07/2021 - 08/2013
3	Messenger RNA (mRNA)IBA 01/2021 - 10/2006
3	Viral DNAIBA 01/2019 - 11/2015
3	Cetuximab (Erbitux)FDA Link 01/2019 - 08/2017
3	C-Reactive ProteinIBA 07/2018 - 01/2015
2	toripalimabIBA 01/2022 - 01/2021
2	nedaplatinIBA 12/2021 - 01/2018
2	EnzymesIBA 10/2021 - 02/2016
2	AlbuminsIBA 09/2021 - 11/2019
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 12/2018
2	Interleukin-6 (Interleukin 6)IBA 07/2020 - 07/2017
2	CytokinesIBA 07/2020 - 11/2019
2	LigandsIBA 01/2020 - 06/2005
2	Docetaxel (Taxotere)FDA Link 01/2020 - 12/2018
2	ChemokinesIBA 01/2020 - 01/2019
2	nitazoxanide (NTZ)FDA Link 01/2019 - 01/2018
2	nimotuzumabIBA 01/2019 - 01/2018
2	Membrane Proteins (Integral Membrane Proteins)IBA 07/2017 - 02/2002
2	Lipoproteins (Lipoprotein)IBA 07/2016 - 08/2014
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2016 - 09/2015
2	Carboplatin (JM8)FDA LinkGeneric 09/2015 - 10/2012
2	Chemokine ReceptorsIBA 08/2013 - 06/2005
2	EndostatinsIBA 05/2013 - 11/2007
2	Endothelin-1 (Endothelin 1)IBA 04/2011 - 04/2006
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	AndrogensIBA 01/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 01/2021
1	angiogeninIBA 01/2021
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 07/2020
1	HLA-DR Antigens (HLA-DR)IBA 07/2020
1	CarbohydratesIBA 07/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	InterferonsIBA 11/2019
1	Antiviral Agents (Antivirals)IBA 11/2019
1	Zoledronic Acid (Zometa)FDA Link 10/2019
1	Oxycodone (Oxycontin)FDA LinkGeneric 10/2019
1	Immune Checkpoint InhibitorsIBA 10/2019

Therapy/Procedure

58	Radiotherapy 11/2022 - 04/2004
40	Drug Therapy (Chemotherapy) 11/2022 - 08/2006
39	Chemoradiotherapy 10/2022 - 10/2009
31	Induction Chemotherapy 01/2022 - 02/2005
23	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 12/2021 - 12/2012
14	Therapeutics 05/2022 - 07/2008
6	Neoadjuvant Therapy 01/2019 - 09/2013
5	Re-Irradiation 01/2020 - 07/2008
4	Adjuvant Chemotherapy 01/2022 - 02/2017
4	Immunotherapy 01/2020 - 02/2015
3	Aftercare (After-Treatment) 10/2019 - 11/2007
3	Neck Dissection (Radical Neck Dissection) 01/2019 - 01/2018
1	TP protocol 01/2022
1	Maintenance Chemotherapy 11/2021
1	Precision Medicine 06/2021
1	Salvage Therapy 01/2020